5 October 2022
Chicago 12, Melborne City, USA

ABVC Biopharma rises on clinical update from Phase 2 trial of ADHD drug (NASDAQ:ABVC)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Leave feedback about this

  • Quality
  • Price
  • Service


Add Field


Add Field
Choose Image
Choose Video